WIRED

@WIRED ↗

Deleted No

Hibernated Yes

Last Checked Jan. 4, 2023

Created

Fri Jul 29 17:34:06 +0000 2022

Likes

Retweets

Source

Twitter Web App

View Raw Data

JSON Data

View on Twitter

Likely Available

WIRED @WIRED

Compass Pathways, a UK-based biotech firm, struck a “sponsored research agreement” with chemist Jason Wallach to try and develop psychedelic drugs for use in mental health therapies. 📸: @tonjethilesen 4/10 https://t.co/7nfFcf4KfS — PolitiTweet.org

Posted July 29, 2022 Hibernated

Preceded By

WIRED @WIRED

The goal is to develop drugs that tickle the 5-HT2A receptor, a cellular protein involved in a range of functions—appetite, imagination, anxiety, sexual arousal. The receptor has proven crucial to understanding the neuropharmacology of the psychedelic experience. 3/10 — PolitiTweet.org

Posted July 29, 2022 Hibernated

Followed By

WIRED @WIRED

Now, Wallach’s once quiet lab—with its beakers, burners and reports on twitchy mice —is helping usher in a new era of Big Neuropharma. But not everyone is thrilled about the potential of “psychedelic capitalism.” 📸: @tonjethilesen 5/10 https://t.co/uEwtLmmcYZ — PolitiTweet.org

Posted July 29, 2022 Hibernated